media – Page 512 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Red Wine and Green Tea could Treat Congenital Inborn Metabolic Diseases

A research team from Tel Aviv University suggested that red wine and green tea could treat certain congenital metabolic diseases, by blocking toxic metabolite formations. Since people with inborn metabolic disorders are born with a defective gene, it leads to a critical enzyme deficiency. Since there is no cure, many patients with congenital metabolic disorders are required to follow a lifelong strict diet.
- Source: Science Daily
- 564
- July 10, 2018
metabolic disease Researches
Smart Bandage to Enhance Wound Healing

The smart bandages used in this research work were designed with heating elements and thermo-responsive drug carriers in order to deliver timely treatments. It combines both temperature and pH sensors to track the signs of infection.
- Source: The Verge
- 1,428
- July 10, 2018
medical device products Researches
Intel Survey that Supports Artificial Intelligence in Healthcare Settings

A recent survey from Intel revealed that health system decision-makers have considered artificial intelligence as a new element of life. Still, many people are anxious as to whether it could provide safe care.
- Source: Healthcare IT
- 637
- July 10, 2018
AI Market Views
FDA Rebukes Chinese API maker Sichuan Friendly Pharmaceutical in Warning Letter

The FDA sent a warning letter to Sichuan Friendly Pharmaceutical after listing it in the import alert list due to its abysmal performance during a fall inspection. The FDA was not pleased with the manufacturing methods it saw at the Chinese API maker’s facility.
- Source: FiercePharma
- 755
- July 9, 2018
FDA pharmaceutical company Policies
Rise in Shares for Biogen, Eisai as Alzheimer’s Drug Succeeds in Mid-Stage Trial.

In a breakthrough finding, revealed through the final analysis of a mid-stage trial, Japanese pharmaceutical firm, Eisai Co and Biogen Inc’s drug for Alzheimer’s proved beneficial for patients who received the highest dose.
- Source: Reuters
- 713
- July 9, 2018
Alzheimer's disease Eisai Market Views
Baclofen, ‘Wonder Drug’ for Alcohol Use Disorder Proves to be Unsuccessful

Baclofen, which was once used to treat spasticity, has started seeing an increase as a prescription for alcohol use disorders. The advantage of Baclofen is that it could be discharged easily through the kidneys to a great extent. Scientists addressed it as a wonder drug due to its effective treatment for alcoholism.
- Source: TechExplorist
- 567
- July 9, 2018
alcohol Researches
Recent Developments in HBV Diagnosis & Treatment

Hepatitis B virus (HBV) causes liver disease that leads to one million deaths throughout the world every year. Extensive research is going on to find the most effective, quick and accurate diagnostic measures followed by therapeutic solutions.
- Source: News Medical
- 688
- July 9, 2018
hepatitis B Researches
Genentech Lawsuit against Eli Lilly’s Antipsoriasis Drug TALZ

Genentech recently won the patent for a psoriasis drug. Unfortunately, Roche’s Genentech unit prosecuted Eli Lilly for violation by claiming their psoriasis drugTalz, infringes on one of their patents.
- Source: FiercePharma
- 979
- July 9, 2018
Company Insight Eli Lilly lawsuit psoriasis Roche
Increased Funding in Digital Health

The digital health world seems to be continuing its rapid growth where around 70 companies' funding results were announced during the second quarter od 2018, totaling to $2 billion.
- Source: MobiHealthNews
- 821
- July 9, 2018
digital health funding Market Views
Gene Editing Control Using Amino Acids

Gene editing and gene therapy can delete disease-causing genes in order to treat specific diseases. But the skill to control unwanted genes is a point of concern, as it might cause severe side effects. A research team from Cardiff University and the University of Bath have devised a switch to control protein expression in mouse embryos, which could be used in human gene therapies in future.
- Source: FierceBiotech
- 661
- July 9, 2018
CRISPR-Cas9 Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.